Bio-Techne (TECH) Return on Capital Employed Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -428.00 |
| Dec 31, 2025 | -473.00 |
| Sep 30, 2025 | -437.00 |
| Jun 30, 2025 | -404.00 |
| Mar 31, 2025 | -161.00 |
| Dec 31, 2024 | -61.00 |
| Sep 30, 2024 | -109.00 |
| Jun 30, 2024 | -16.00 |
| Mar 31, 2024 | 160.00 |
| Dec 31, 2023 | 209.00 |
| Sep 30, 2023 | 338.00 |
| Jun 30, 2023 | 308.00 |
| Mar 31, 2023 | 338.00 |
| Dec 31, 2022 | 459.00 |
| Sep 30, 2022 | 508.00 |
| Jun 30, 2022 | 543.00 |
| Mar 31, 2022 | 462.00 |
| Dec 31, 2021 | 298.00 |
| Sep 30, 2021 | -44.00 |
| Jun 30, 2021 | -231.00 |
| Mar 31, 2021 | -299.00 |
| Dec 31, 2020 | -354.00 |
| Sep 30, 2020 | -464.00 |
| Jun 30, 2020 | -583.00 |
| Mar 31, 2020 | -528.00 |
| Dec 31, 2019 | -658.00 |
| Sep 30, 2019 | -880.00 |
| Jun 30, 2019 | -1,122.00 |
| Mar 31, 2019 | 93.00 |
| Dec 31, 2018 | 84.00 |
| Sep 30, 2018 | 62.00 |
| Jun 30, 2018 | 130.00 |
| Mar 31, 2018 | -1,372.00 |
| Dec 31, 2017 | -1,462.00 |
| Sep 30, 2017 | -1,535.00 |
| Jun 30, 2017 | -1,641.00 |
| Mar 31, 2017 | -1,818.00 |
| Dec 31, 2016 | -1,777.00 |
| Sep 30, 2016 | -1,553.00 |
| Jun 30, 2016 | -1,396.00 |
| Mar 31, 2016 | 327.00 |
| Dec 31, 2015 | 293.00 |
| Sep 30, 2015 | 309.00 |